RA2 DREAM Challenge
Learn More The purpose of the RA2-DREAM Challenge is to develop an automated method to quickly and accurately quantify the degree
DREAM Challenges Announces Changes in its Leadership that Support a Rich Future in Open Benchmarking
SEATTLE – DREAM Challenges has announced changes to its governance and leadership to reflect its vision for future growth. DREAM is a volunteer
EHR DREAM Challenge – Patient Mortality Prediction
Learn More Healthcare institutions are attempting to move away from a rules-based approach to clinical care, toward a more data-driven model
Allen Institute Cell Lineage Reconstruction DREAM Challenge
Learn More The advent of new CRISPR-based molecular tools allows the reconstruction of cell lineages based on the phylogenetical analysis of
Single-Cell Signaling in Breast Cancer DREAM Challenge
Learn More Signaling underlines nearly every cellular event. Individual cells, even if genetically identical, respond to perturbation in different ways. This
Electronic Medical Record NLP DREAM Challenge
Closed A critical bottleneck in translational and clinical research is access to large volumes of high-quality clinical data. While structured data
Tumor Deconvolution DREAM Challenge
Learn More The extent of stromal and immune cell infiltration within solid tumors has prognostic and predictive significance. Unfortunately, expression profiling
Idea Competition Winner Announced for the CTSA Program
The CD2H Idea Competition for the CTSA Program is pleased to announce the winner of the Idea Challenge Competition: University of Alabama,
Preterm Birth Prediction: Transcriptomics
Learn More A basic need in pregnancy care is to establish gestational age, and inaccurate estimates may lead to unnecessary interventions
Malaria DREAM Challenge
Learn More The Malaria DREAM Challenge is open to anyone interested in contributing to the development of computational models that address
PrecisionFDA and NCI CPTAC Announce the Best Performers in Multi-omics Sample Mislabeling Big Data Challenge
PrecisionFDA and the National Cancer Institute’s (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) (in coordination with DREAM Challenges) are pleased to announce
IDG-DREAM Drug-Kinase Binding
Learn More Mapping the complete target space of drugs and drug-like compounds, including both intended ‘primary targets’ as well as secondary
Subscribe to our Newsletter